Concepedia

Publication | Closed Access

Prevalence of advanced hepatic fibrosis and comorbidity in metabolic dysfunction‐associated fatty liver disease in Korea

37

Citations

24

References

2022

Year

Abstract

The sex- and age-standardized prevalence of advanced fibrosis was 3.0% (range: 2.6-4.6%) in subjects with MAFLD.

References

YearCitations

Page 1